From the Blog of the Legal Times:
The Justice Department is planning to focus more criminal enforcement against the pharmaceutical industry’s interaction with foreign officials, the head of the department’s Criminal Division warned today.
Assistant Attorney General Lanny Breuer, addressing the 10th Annual Pharmaceutical Regulatory and Compliance Congress and Best Practices Forum, said the application of the Foreign Corrupt Practices Act to the pharmaceutical industry will be pushed “in the months and years ahead.” He noted the depth of government involvement in foreign health care systems and said it creates a “significant risk that corrupt payments will infect the process…”
